Pharmafile Logo

Medscape at ASH 2025: Landmark Value Through the Medscape AI Debut and Five Educational Symposia

December 1, 2025 |  

- PMLiVE

For decades, Medscape has been the brand physicians trust. Now, Medscape is forging a new path into the future at ASH 2025 with the launch of Medscape AI — the first and only medical-grade Generative AI experience that integrates Medscape’s proprietary content, peer-reviewed literature, and real-time medical news to deliver timely, trustworthy, specialty-specific insights that support informed decision-making.

Medscape AI marks a transformation from a single search tool to a robust platform of integrated AI-powered solutions for HCPs. This shift emphasizes integration, bringing together multiple AI capabilities designed to support clinicians in all aspects of their practice, beyond just search, making the evolution substantial and future-oriented with exciting developments to come. 

Among the proven benefits of Medscape AI:

  • Reliability: Clinically Vetted Sources, Transparent By Design
    • Built on both Medscape’s trusted proprietary content and evidence from 400+ of the most prestigious peer-reviewed journals across a wide range of specialties — spanning oncology, cardiology, dermatology, internal medicine, and beyond — with no unverified material from the open internet
    • AI responses are traceable, transparent, and supported by citations 
  • Recency: Always Current and Continuously Updated
    • Integrates verified real-time news, research updates, and guideline changes
    • Daily and weekly editorial oversight ensures outputs reflect the latest evidence 
  • Relevance: Aligned to Practice and Patient Care
    • Jointly built with practicing clinicians to bridge the gap between AI innovations and clinical reality
    • Synthesized insights tuned to each specialty, workflow, and clinical context
    • Guidance supports differential diagnosis, treatment decisions, and next-step care
    • Integrated across the Medscape experience, including the industry-leading Medscape newsreader and point-of-care decision support tools  
  • Time-Saving Clinical Efficiency
    • Digestible, actionable responses free up clinicians to focus more on patient care and less time searching and reviewing literature

“As AI becomes essential to modern clinical practice, it not only needs to unlock unmatched value to our users, it must also meet the rigorous standards clinicians require: accurate, current, and evidence-based,” said Bob Brisco, CEO of Medscape’s parent company, Internet Brands. “Medscape AI delivers this and more. It cuts through the information overload plaguing healthcare professionals, synthesizing evidence instantly to drive better patient outcomes. It’s clinical precision in your pocket – expert guidance that’s tailored to meet your exact query, grounded in evidence, and powered by Medscape’s human-validated compendium of medical expertise.”

Medscape  is advancing medical education through data-driven insights and innovative technology . Focused on the oncology and hematology community at ASH 2025, Medscape Education delivers transformative CME solutions that go beyond knowledge transfer to impact real-world clinical behavior, and, most critically, patient outcomes. Between 2023 and 2025 Medscape’s learning design and scientific content teams have delivered 102 programs in hematology, reaching 836,531 learners, who are potentially impacting over 3 million patients per month. 

 Visit booth #443 to explore our comprehensive hematology education offerings and get hands-on experience with the new Medscape AI feature!

Educational Symposia

Join us on Friday, December 5, 2025 for 5 Medscape Oncology educational symposia designed to help clinicians translate the latest clinical data into practice. Register here.

  • Rare Clinical Spotlight: Exploring Castleman Disease, Cold Agglutinin Disease and Acute Intermittent Porphyria
    • Time: 11:30 AM – 1:00 PM ET
    •  Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK
  • Targeted Therapies in R/R PCNSL: New Frontiers in Treatment and Management
    • Time: 11:30 AM – 1:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International DEFG 
  • Tailoring Bispecific Antibodies to Individualize R/R Follicular Lymphoma Care: A Case-Based Discussion
    • Time: 11:30 AM – 1:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Personalizing Relapsed/Refractory DLBCL With Bispecific Antibody Therapy: A Case-Based Discussion
    • Time: 3:30 PM – 5:00 PM ET
    •  Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819
    • Room: W311 EFGH
  • Acute Hepatic Porphyria: Bridging Gaps for Better Diagnosis and Management
    • Time: 3:30 PM – 5:00 PM ET
    • Hyatt Regency Orlando, 9801 International Drive, Orlando, Florida, 32819
    • Room: Plaza International HIJK

ASH Abstract Publication 

Michelle Worst, PharmD, BCOP, MBA, CHCP has an online abstract accepted at ASH 2025. The abstract, titled “Assessing the influence of live and online enduring CME activities presented at the 66th ASH annual meeting on hematology/oncology specialists using pre-/post-education evaluations,” will be published online-only on the ASH abstracts site in the November supplemental issue of Blood

For more information, please contact Jelena Spyropoulos.

This content was provided by Medscape Education

Company Details

 Latest Content from  Medscape Education 

Showing Deep Expertise at ONS

The Medscape Oncology team will be connecting with the oncology nursing community this week in Washington, DC for the ONS Congress 2024.  Medscape Oncology has deep expertise in the oncology...

MEDSCAPE’S NEW AGE OF CERTAINTY FOR CME

The CME industry is changing. More than ever, activities need to be prioritized and measured to increase their impact on patient outcomes. Improving patient outcomes is the core objective for...

Getting Past the Old-Fashioned View of Patient Advocacy

Patient advocacy organizations today are data-driven, doing amazing work — and have the hard evidence to support their impact on patient care. The challenge is getting past the perception of...

Mile High Impact at AAN 2024

The Medscape team will be joining our neurology colleagues in Denver, CO for this year’s AAN Annual Meeting. Impact will take center stage at this year’s event as Medscape presents...

Everything Was Peachy at ACC 2024 in Atlanta, GA

The annual ACC meeting has officially wrapped up in Atlanta, bringing a successful conference to a close for another year.  During the conference, members of the Medscape team hosted a...

A Woman Should Not Be Treated As a Small Man

What should the future of women’s healthcare look like? Two renowned physicians say it involves a multidisciplinary, holistic approach, where a group of different specialists work together to provide a...

Sharing Four Times the Impact at ACC 2024

ACC is kicking off next week in Atlanta, GA, and Medscape is heading south to join our cardiology colleagues. The Medscape team will be hosting booth #3431 on the exhibit...

Transforming San Diego for AAD 2024

The 2024 meeting of the American Academy of Dermatology has wrapped up, and Medscape has returned from a series of successful days at their booth, symposia, and offsite event. To...

The Power Dynamics of Women and Cancer

Women, Power, and Cancer: a Lancet commission, studied the interaction of women and cancer through a social justice and equity lens. What does ‘power’ mean when it comes to cancer...

Evaluating the Forces Shaping Women’s Healthcare

Gaps in women’s healthcare go beyond access and cost. Do clinicians have the tools they need to understand women’s health?